Logo
Menu
Overview

Summary

Contact details2

Officers1

Related companies1

FAQ

Find out all the information about TRICARE PHARMACEUTICAL NIGERIA LIMITED
by getting full access

Last updated: Jun 15, 2024

TRICARE PHARMACEUTICAL NIGERIA LIMITED

Active

is not in process of liquidation on Jun 15, 2024

Private company limited by shares

Nigeria 14 Aug 2009 (15 years ago)

Share viaTwitterFacebookLinkedin

Summary

NameTRICARE PHARMACEUTICAL NIGERIA LIMITED
Historical names
  • TRICARE PHARM NIGERIA LIMITED
Status
  • ActiveActive
JurisdictionActiveNigeria
Registration number (RC)CodeRC-838511
Registry number838511
Incorporation Date14 Aug 2009 (15 years ago) / 420 companies with the same date
Paid share capital10000000 NGN
Value of shares0.01 NGN
Shares issued10000000
Legal formPrivate company limited by shares
Type of activity
  • Primary:
  • #143269 - Other personal services activities
  • Description:
  • TO GO INTO BUSINESS AS PHARMACISTS AND PHARMACEUTICAL CHEMISTS AND THEREBY ENGAGE IN THE ENGAGE IN THE RESEARCH ,TESTING TRAILS,MANUFACTURE,DISTRIBUTION,SALE AND RETAIL OF ALL MANNERS OF DRUGS ,PHARMACEUTICAL COMPOUNDS,MEDICAL AIDS ,FOOD SUPPLEMENTS ETC.

Contact details

Legal addressNO. 28 OSOLO WAY, AJAO ESTATE, ISOLO, LAGOS STATE
People
Chi***** Don*** Mgb******don******************+23**************

Officers

individual

IndividualNigeria

Chijioke Donald Mgbonyebi

Accountant


Country of residenceNIGERIA

Get ahead with complete company information - register now.

Join the 50,000+ businesses already using B2BHint.

Sign up

Frequently asked questions

Where is TRICARE PHARMACEUTICAL NIGERIA LIMITED's headquarters?

TRICARE PHARMACEUTICAL NIGERIA LIMITED's headquarters is located at NO. 28 OSOLO WAY, AJAO ESTATE, ISOLO, LAGOS STATE

What is TRICARE PHARMACEUTICAL NIGERIA LIMITED's industry?

TRICARE PHARMACEUTICAL NIGERIA LIMITED is in the industry of Other personal services activities

What year was TRICARE PHARMACEUTICAL NIGERIA LIMITED started?

TRICARE PHARMACEUTICAL NIGERIA LIMITED was started in 2009

Sources: Corporate Affairs Commission